Sonoco ProductsNYSE: SON

SON Q3 top line reflects the impacts of the Protective Solutions divestiture and the thermoformed food packaging plant closure.

Sonoco Products Company (NYSE:SON ) Q3 2024 Earnings Call Transcript November 1, 2024 8:30 AM ET Company Participants Lisa Weeks - VP of IR Howard Coker - President and CEO Rob Dillard - CFO Rodger Fuller - COO Conference Call Participants George Staphos - Bank of America Securities Ghansham Panjabi - Baird Matt Roberts - Raymond James Anthony Pettinari - Citi Mark Weintraub - Seaport Research Partners Gabe Hajde - Wells Fargo Operator Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator today.

Sonoco (SON) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.44 per share. This compares to earnings of $1.46 per share a year ago.

Sonoco (SON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HARTSVILLE, S.C., Oct. 15, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Sonoco (NYSE: SON) has declared a $0.52 per share quarterly common stock dividend. This dividend will be paid on December 10, 2024, to shareholders of record as of November 8, 2024.

Investors interested in Containers - Paper and Packaging stocks are likely familiar with Sonoco (SON) and Packaging Corp. (PKG). But which of these two companies is the best option for those looking for undervalued stocks?

SON-1010 is a targeted immune activation cancer therapy designed to turn ‘cold' tumors ‘hot' Topline safety data of SB101 Phase 1 study expected by Q4 2024 PRINCETON, NJ, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced the completion of enrollment and initiation of dosing in its Phase 1 SB101 clinical trial of SON-1010 (IL12-FHAB) in adult patients with advanced solid tumors.

HARTSVILLE, S.C., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), a global leader in high-value sustainable packaging, today announced that it has priced an offering (the “Offering”) of senior unsecured notes in a combined aggregate principal amount of $1.8 billion (collectively, the “Notes”).

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.